Jubilant Pharmova's wholly owned subsidiary Jubilant Pharma, today announced that its subsidiary Jubilant Generics (JGL) received a communication from the USFDA through which the regulatory agency intimated that pursuant to its January 25 to February 2, 2024 audit of JGL's Solid dosage manufacturing facility at Roorkee
Dräger, a global leader in medical and safety technology has launched Vista 300 in India, a ground-breaking patient monitoring system designed to streamline information flow across hospital departments.
DELRAY BEACH, Fla., April 16, 2024 (GLOBE NEWSWIRE) -- UpHealth, Inc. (UpHealth) (OTC: UPHL), a leading provider of a full continuum of behavioral health solutions through the utilization of...
Pharmaceutical exports from India have been encountering significant hurdles in recent months, as a 30% reduction in business volume coincides with a doubling of transit times due to disruptions in the Red Sea caused by the Israel-Hamas conflict. Freight forwarders, directly impacted by the slowdown, have reported the adverse effects on the industry.
The Central Drugs Standard Control Organisation (CDSCO) has released a draft of revised Guidance for Industry document, in consultation with the stakeholders to align with the New Drugs and Clinical Trials (NDCT) Rules, 2019 and the Sugam application process.
Labcorp, a global leader of innovative and comprehensive laboratory services, announced the availability of the nation's first test for glial fibrillary acidic protein (GFAP), a critical blood-based biomarker for the early detection of neurodegenerative diseases and neurological injuries.
Cresset an innovative provider of solutions for CADD, DMTA efficiency, and contract research, has expanded its senior leadership team with the appointment of Cambridge Scientist Dr. Mutlu Dogruel to the newly created position of vice president for AI Solutions.
Suven Life Sciences, a clinical-stage biopharmaceutical company discovering and developing novel medicines to treat Central Nervous System (CNS) disorders, announced today scientific presentation at the upcoming 76th American Academy of Neurology (AAN) annual meeting being held April 13-18, 2024, in Denver, USA and virtually.
Laurus Labs Limited has announced that a Joint Venture Company named KRKA Pharma Private Limited. The JV Company got incorporated in India effective April 12, 2024 pursuant to the joint venture agreement dated January 25, 2024 between Laurus Labs Limited and KRKA, an international generic pharmaceutical company in Novo Mesto, Slovenia.